Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Possible increased risk for Alzheimer's disease associated with neprilysin gene.

Clarimón J, Muñoz FJ, Boada M, Tàrraga L, Sunyer J, Bertranpetit J, Comas D.

J Neural Transm (Vienna). 2003 Jun;110(6):651-7.

PMID:
12768360
2.

Association between acyl-coenzyme A: cholesterol acyltransferase gene and risk for Alzheimer's disease in Chinese.

Zhao FG, Wang YH, Yang JF, Ma QL, Tang Z, Dong XM, Chan P.

Neurosci Lett. 2005 Nov 4;388(1):17-20.

PMID:
16043284
3.

Lack of association of neprilysin gene polymorphisms with Alzheimer's disease in a southern Chinese community.

Fu Y, Li AF, Shi JJ, Tang MN, Guo YB, Zhao ZH.

Int Psychogeriatr. 2009 Apr;21(2):354-8. doi: 10.1017/S1041610208008338. Epub 2009 Mar 2.

PMID:
19250583
4.

Association between neprilysin polymorphisms and sporadic Alzheimer's disease.

Wood LS, Pickering EH, McHale D, Dechairo BM.

Neurosci Lett. 2007 Nov 5;427(2):103-6. Epub 2007 Sep 20.

PMID:
17928142
5.

Lack of association of neprilysin polymorphism with Alzheimer's disease and Alzheimer's disease-type neuropathological changes.

Sodeyama N, Mizusawa H, Yamada M, Itoh Y, Otomo E, Matsushita M.

J Neurol Neurosurg Psychiatry. 2001 Dec;71(6):817-8. No abstract available.

6.

Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease.

Oda M, Morino H, Maruyama H, Terasawa H, Izumi Y, Torii T, Sasaki K, Nakamura S, Kawakami H.

Neurosci Lett. 2002 Mar 1;320(1-2):105-7.

PMID:
11849775
7.

Mutation screening and association study of the neprilysin gene in sporadic Alzheimer's disease in Chinese persons.

Shi J, Zhang S, Tang M, Ma C, Zhao J, Li T, Liu X, Sun Y, Guo Y, Han H, Ma Y, Zhao Z.

J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):301-6.

PMID:
15860464
8.

Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients.

Helisalmi S, Hiltunen M, Vepsäläinen S, Iivonen S, Mannermaa A, Lehtovirta M, Koivisto AM, Alafuzoff I, Soininen H.

J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1746-8.

9.

Association of NAD(P)H:quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese.

Bian JT, Zhao HL, Zhang ZX, Bi XH, Zhang JW.

J Mol Neurosci. 2008 Mar;34(3):235-40. doi: 10.1007/s12031-008-9036-z. Epub 2008 Feb 6.

PMID:
18253865
10.

Association of the Neprilysin gene with susceptibility to late-onset Alzheimer's disease.

Sakai A, Ujike H, Nakata K, Takehisa Y, Imamura T, Uchida N, Kanzaki A, Yamamoto M, Fujisawa Y, Okumura K, Kuroda S.

Dement Geriatr Cogn Disord. 2004;17(3):164-9. Epub 2004 Jan 20.

PMID:
14739539
11.

Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.

Tayler H, Fraser T, Miners JS, Kehoe PG, Love S.

J Alzheimers Dis. 2010;22(4):1363-73. doi: 10.3233/JAD-2010-101368.

PMID:
20930272
12.
13.

Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.

Geroldi D, Minoretti P, Bianchi M, Di Vito C, Reino M, Bertona M, Emanuele E.

Neurosci Lett. 2005 Oct 7;386(3):176-8.

PMID:
16002217
14.

Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk.

Combarros O, Sánchez-Juan P, Riancho JA, Mateo I, Rodríguez-Rodríguez E, Infante J, García-Gorostiaga I, Vázquez-Higuera JL, Berciano J.

J Neural Transm (Vienna). 2008 Jun;115(6):863-7. doi: 10.1007/s00702-008-0028-5. Epub 2008 Feb 26.

PMID:
18299793
15.

Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease.

Lambert JC, Luedecking-Zimmer E, Merrot S, Hayes A, Thaker U, Desai P, Houzet A, Hermant X, Cottel D, Pritchard A, Iwatsubo T, Pasquier F, Frigard B, Conneally PM, Chartier-Harlin MC, DeKosky ST, Lendon C, Mann D, Kamboh MI, Amouyel P.

J Med Genet. 2003 Jun;40(6):424-30.

16.

Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).

Déniz-Naranjo MC, Muñoz-Fernández C, Alemany-Rodríguez MJ, del Carmen Pérez-Vieitez M, Aladro-Benito Y, Irurita-Latasa J, Sánchez-García F.

Neurosci Lett. 2007 Oct 29;427(1):34-8. Epub 2007 Sep 4.

PMID:
17923322
17.

Accumulation of murine amyloid-β mimics early Alzheimer's disease.

Krohn M, Bracke A, Avchalumov Y, Schumacher T, Hofrichter J, Paarmann K, Fröhlich C, Lange C, Brüning T, von Bohlen Und Halbach O, Pahnke J.

Brain. 2015 Aug;138(Pt 8):2370-82. doi: 10.1093/brain/awv137. Epub 2015 May 18.

PMID:
25991605
18.

γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease.

Klein C, Mathis C, Leva G, Patte-Mensah C, Cassel JC, Maitre M, Mensah-Nyagan AG.

Neurobiol Aging. 2015 Feb;36(2):832-44. doi: 10.1016/j.neurobiolaging.2014.10.003. Epub 2014 Oct 13.

PMID:
25457559
19.

Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.

Clarimón J, Bertranpetit J, Calafell F, Boada M, Tàrraga L, Comas D.

J Neurol. 2003 Aug;250(8):956-61.

PMID:
12928915
20.

Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.

Spencer B, Marr RA, Rockenstein E, Crews L, Adame A, Potkar R, Patrick C, Gage FH, Verma IM, Masliah E.

BMC Neurosci. 2008 Nov 12;9:109. doi: 10.1186/1471-2202-9-109.

Supplemental Content

Support Center